MGLN

Magellan Health Inc.

Price

return (12m)

0.00%

p/e

8.00

p/bv

1.53

DIVIDEND YIELD

0.00%

MGLN price

Magellan Health

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MGLN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals MGLN

Valuation

P/E

8.00

Sector -2.34

Industry 11.10

P/BV

1.53

Sector 2.17

Industry 3.33

P/Revenue (PSR)

0.51

Sector 2.00

Industry 1.71

EV/EBITDA

Sector -23.69

Industry -398.52

EV/EBIT

Sector -36.60

Industry -80.73

P/EBITDA

7.32

Sector -0.10

Industry 8.30

P/EBIT

9.49

Sector -2.08

Industry 5.69

P/Total Assets

0.71

Sector 1.18

Industry 1.57

P/Net Current Assets

Sector -10.91

Industry -3.38

P/Working Capital

Sector 0.09

Industry 10.51

EPS

11.87

Sector -0.93

Industry 1.10

BVPS

62.05

Sector 3.87

Industry 14.82

Efficiency

Gross Margin

2.48%

Sector 44.28%

Industry 29.23%

EBITDA Margin

1.42%

Sector -291.45%

Industry 4.29%

EBIT Margin

1.36%

Sector -195.44%

Industry 1.44%

Operating Margin

0.48%

Sector -25.72%

Industry 2.16%

Net Profit Margins

6.38%

Sector -30.19%

Industry 2.77%

Asset Turnover

0.35

Sector 0.12

Industry 0.27

Profitability

ROE

19.13%

Sector -34.71%

Industry 6.97%

ROA

8.93%

Sector -28.76%

Industry 2.97%

ROIC

Sector -441.27%

Industry -5.31%

Dividends

Dividend yield

0.00%

Sector -

Industry 0.01%

Payout

0.00%

Sector -

Industry 0.54%

Debt

Current Ratio

Sector 1.87

Industry 1.51

Net Debt / EBITDA

Sector -2.18

Industry -1.68

Net Debt / EBIT

Sector -0.74

Industry -7.00

Net Debt / Equity

Sector -0.34

Industry 0.05

Gross Debt / Equity

Sector -0.64

Industry 0.35

Equity/Assets

0.47

Sector 0.43

Industry 0.46

Liabilities/Assets

0.47

Sector 0.46

Industry 0.52

Growth

5Y Revenue CAGR

5.93%

Sector -

Industry -

5Y Earnings CAGR

55.62%

Sector -

Industry -

FAIR VALUE OF Magellan Health ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$0.00

Fair Value

$128.73

Upside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals MGLN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
MGLN Magellan Health Inc.	$0.00	-	0.00%	8.00	1.53	19.13%	6.38%
ENSG The Ensign Group, Inc	$198.45	55.39%	0.15%	27.54	4.22	15.33%	6.89%
CRVL CorVel Corporation	$55.12	-53.55%	0.00%	28.24	7.90	27.99%	11.51%
JYNT The Joint Corp.	$8.98	-13.65%	0.00%	38.39	8.03	20.92%	5.72%
UHS Universal Health Services Inc.	$181.95	4.14%	0.53%	6.06	1.21	20.00%	8.56%
DGX Quest Diagnostics Inc.	$194.11	21.09%	1.55%	22.66	3.00	13.22%	9.08%
PGNY Progyny Inc.	$17.17	-23.14%	0.00%	37.63	5.80	15.40%	5.23%
CI Cigna Corp.	$272.65	-15.68%	2.16%	11.58	1.78	15.39%	2.34%
VAR Varian Medical Systems Inc.	$0.00	-	0.00%	58.58	7.26	12.40%	5.85%
PNTG The Pennant Group Inc.	$30.65	20.81%	0.00%	48.21	3.75	7.79%	2.96%
STRRP Star Equity Holdings Inc.	$10.14	35.21%	9.43%	8.16	2.56	31.31%	25.96%
OPCH Option Care Health Inc.	$27.89	-11.62%	0.00%	16.48	2.51	15.26%	3.64%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MGLN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Magellan Health

Magellan Health Inc.

Average Investor10 user rating

4.0 (0 people)

States of America

57 years

Founded: 1969

2004

Time since IPO - 22 years

9.000

Employees

Magellan Health Inc. (States of America) is listed on the Nasdaq and has a market capitalization of $2.42 billion, with shareholders equity totaling $1.58 billion.

The company employs approximately 9.000 people and operates in the Saúde sector, within the Estabelecimentos de Saúde industry.

Over the past 12 months, Magellan Health Inc. reported $4.74 billion in revenue, generating net income of $302.03 million.

Key financial metrics include a P/E ratio of 8.00, a price-to-book (P/B) ratio of 1.53, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MGLN.

Market cap

$2.42 billion

Net worth

$1.58 billion

$1,579,152,000.00

Assets

$3.38 billion

$3,381,020,000.00

Total Shares Outstanding

25.45 million

25,448,000

Average Daily Trading Volume

$177.91 Thousand

$177,908.80

Sector

Saúde

Industry

Estabelecimentos de Saúde

MGLN

MGLN revenue and profits

Financial Results MGLN

DRAG THE FRAME TO SEE MORE DATA

MGLN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$77.63 34,88% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$272.65 --5,23% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$37.26 38,72% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$196.30 --14,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$47.64 --3,72% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$923.03 21,62% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$498.78 47,18% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$153.41 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56